Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T

Application to schizophrenia

Melissa Terpstra, J. T Vaughan, Kamil Ugurbil, Kelvin O Lim, S. Charles Schulz, Rolf Gruetter

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Objective: Quantitation of glutathione (GSH) in the human brain in vivo using short echo time 1 H NMR spectroscopy is challenging because GSH resonances are not easily resolved. The main objective of this study was to validate such quantitation in a clinically relevant population using the resolved GSH resonances provided by edited spectroscopy. A secondary objective was to compare several of the neurochemical concentrations quantified along with GSH using LCModel analysis of short echo time spectra in schizophrenia versus control. Materials and Methods: GSH was quantified at 4T from short echo STEAM spectra and MEGA-PRESS edited spectra from identical volumes of interest (anterior cingulate) in ten volunteers. Neurochemical profiles were quantified in nine controls and 13 medicated schizophrenic patients. Results: GSH concentrations as quantified using STEAM, 1.6 ± 0.4 μmol/g (mean ± SD, n=10), were within error of those quantified using edited spectra, 1.4 ± 0.4 μmol/g, and were not different (p=0.4). None of the neurochemical measurements reached sufficient statistical power to detect differences smaller than 10% in schizophrenia versus control. As such, no differences were observed. Conclusions: Human brain GSH concentrations can be quantified in a clinical setting using short-echo time STEAM spectra at 4T.

Original languageEnglish (US)
Pages (from-to)276-282
Number of pages7
JournalMagnetic Resonance Materials in Physics, Biology and Medicine
Volume18
Issue number5
DOIs
StatePublished - Oct 1 2005

Fingerprint

Glutathione
Schizophrenia
Magnetic Resonance Spectroscopy
Gyrus Cinguli
Brain
Volunteers
Spectrum Analysis
Population
Proton Magnetic Resonance Spectroscopy

Keywords

  • Glutathione
  • Magnetic resonance spectroscopy
  • Schizophrenia

Cite this

@article{defb26abc85b40eda2cbc888f3c80e92,
title = "Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: Application to schizophrenia",
abstract = "Objective: Quantitation of glutathione (GSH) in the human brain in vivo using short echo time 1 H NMR spectroscopy is challenging because GSH resonances are not easily resolved. The main objective of this study was to validate such quantitation in a clinically relevant population using the resolved GSH resonances provided by edited spectroscopy. A secondary objective was to compare several of the neurochemical concentrations quantified along with GSH using LCModel analysis of short echo time spectra in schizophrenia versus control. Materials and Methods: GSH was quantified at 4T from short echo STEAM spectra and MEGA-PRESS edited spectra from identical volumes of interest (anterior cingulate) in ten volunteers. Neurochemical profiles were quantified in nine controls and 13 medicated schizophrenic patients. Results: GSH concentrations as quantified using STEAM, 1.6 ± 0.4 μmol/g (mean ± SD, n=10), were within error of those quantified using edited spectra, 1.4 ± 0.4 μmol/g, and were not different (p=0.4). None of the neurochemical measurements reached sufficient statistical power to detect differences smaller than 10{\%} in schizophrenia versus control. As such, no differences were observed. Conclusions: Human brain GSH concentrations can be quantified in a clinical setting using short-echo time STEAM spectra at 4T.",
keywords = "Glutathione, Magnetic resonance spectroscopy, Schizophrenia",
author = "Melissa Terpstra and Vaughan, {J. T} and Kamil Ugurbil and Lim, {Kelvin O} and Schulz, {S. Charles} and Rolf Gruetter",
year = "2005",
month = "10",
day = "1",
doi = "10.1007/s10334-005-0012-0",
language = "English (US)",
volume = "18",
pages = "276--282",
journal = "Magnetic Resonance Materials in Physics, Biology, and Medicine",
issn = "0968-5243",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T

T2 - Application to schizophrenia

AU - Terpstra, Melissa

AU - Vaughan, J. T

AU - Ugurbil, Kamil

AU - Lim, Kelvin O

AU - Schulz, S. Charles

AU - Gruetter, Rolf

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Objective: Quantitation of glutathione (GSH) in the human brain in vivo using short echo time 1 H NMR spectroscopy is challenging because GSH resonances are not easily resolved. The main objective of this study was to validate such quantitation in a clinically relevant population using the resolved GSH resonances provided by edited spectroscopy. A secondary objective was to compare several of the neurochemical concentrations quantified along with GSH using LCModel analysis of short echo time spectra in schizophrenia versus control. Materials and Methods: GSH was quantified at 4T from short echo STEAM spectra and MEGA-PRESS edited spectra from identical volumes of interest (anterior cingulate) in ten volunteers. Neurochemical profiles were quantified in nine controls and 13 medicated schizophrenic patients. Results: GSH concentrations as quantified using STEAM, 1.6 ± 0.4 μmol/g (mean ± SD, n=10), were within error of those quantified using edited spectra, 1.4 ± 0.4 μmol/g, and were not different (p=0.4). None of the neurochemical measurements reached sufficient statistical power to detect differences smaller than 10% in schizophrenia versus control. As such, no differences were observed. Conclusions: Human brain GSH concentrations can be quantified in a clinical setting using short-echo time STEAM spectra at 4T.

AB - Objective: Quantitation of glutathione (GSH) in the human brain in vivo using short echo time 1 H NMR spectroscopy is challenging because GSH resonances are not easily resolved. The main objective of this study was to validate such quantitation in a clinically relevant population using the resolved GSH resonances provided by edited spectroscopy. A secondary objective was to compare several of the neurochemical concentrations quantified along with GSH using LCModel analysis of short echo time spectra in schizophrenia versus control. Materials and Methods: GSH was quantified at 4T from short echo STEAM spectra and MEGA-PRESS edited spectra from identical volumes of interest (anterior cingulate) in ten volunteers. Neurochemical profiles were quantified in nine controls and 13 medicated schizophrenic patients. Results: GSH concentrations as quantified using STEAM, 1.6 ± 0.4 μmol/g (mean ± SD, n=10), were within error of those quantified using edited spectra, 1.4 ± 0.4 μmol/g, and were not different (p=0.4). None of the neurochemical measurements reached sufficient statistical power to detect differences smaller than 10% in schizophrenia versus control. As such, no differences were observed. Conclusions: Human brain GSH concentrations can be quantified in a clinical setting using short-echo time STEAM spectra at 4T.

KW - Glutathione

KW - Magnetic resonance spectroscopy

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=28444492999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28444492999&partnerID=8YFLogxK

U2 - 10.1007/s10334-005-0012-0

DO - 10.1007/s10334-005-0012-0

M3 - Article

VL - 18

SP - 276

EP - 282

JO - Magnetic Resonance Materials in Physics, Biology, and Medicine

JF - Magnetic Resonance Materials in Physics, Biology, and Medicine

SN - 0968-5243

IS - 5

ER -